Ligand · 2Q9
2Q9 · 2,7,7-trimethyl-9-[1-oxo-8-(propan-2-ylamino)-1,2,3,4-tetrahydroisoquinolin-6-yl]-1,2,3,4,6,7,8,9-octahydro-5H-beta-carbolin-5-one
2Q9, 2,7,7-trimethyl-9-[1-oxo-8-(propan-2-ylamino)-1,2,3,4-tetrahydroisoquinolin-6-yl]-1,2,3,4,6,7,8,9-octahydro-5H-beta-carbolin-5-one (C26 H34 N4 O2, 434.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry).…
- Component
- 2Q9
- Formula
- C26 H34 N4 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
2Q9 in 2 structures; the first of them:
- 4O05 · Identification of novel HSP90/isoform selective inhibitors using structure-based drug… · 2Q9 A4000 · binds LEU48, ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97 and 13 more
- 4O05 · Identification of novel HSP90/ISOFORM selective inhibitors using structure-based drug… · 2Q9 A4000 · binds LEU48, ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97 and 13 more
Residues it binds most
GLY 2, LEU 2, ALA 2, ASP 2, VAL 2, ASN 2, ILE 2, LYS 2, MET 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.